Kamal Kishore Sharma

Kamal Kishore Sharma is currently Chairman at Viyash Scientific Ltd. and Alivira Animal Health Ltd., Non-Executive Chairman at Shalina Healthcare Ltd., and Director at Laboratorios Karizoo SA, Symed Laboratories Ltd., Shalina Healthcare DMCC FZE, Viyash Life Sciences Pvt Ltd., Generic Health Pty Ltd., Pharma Dynamics Pty Ltd., Lupin Healthcare Ltd., Faisa Financial Pvt Ltd., Templetree Properties Pvt Ltd., Lupin GmbH, Templecraft Realty LLP, Templeriviere Property LLP, Assetz Buildwell LLP, Temple Wellness Ventures LLP, and Senior Advisor at The Carlyle Group LP (Global Private Equity).
Also holds the position of Independent Director at Alivira Animal Health Ltd. (Ireland).
Formerly President & Chief Executive Officer at RPG Life Sciences Ltd. from 1995 to 2003, Non-Executive Vice Chairman at Lupin Ltd. from 2013 to 2022, Independent Director at Shilpa Medicare Ltd. from 2022 to 2025, Chairman at Kyowa Pharmaceutical Industry Co., Ltd., Managing Director at Lupin Chemicals Ltd., and Member-Management Board at R P G Enterprises Ltd. Education includes undergraduate degree from Indian Institute of Technology Kanpur, doctorate from Indian Institute of Technology Bombay, and undergraduate degree from Harvard Business School.